Lisata Therapeutics, Inc.
LSTA
$1.93
$0.031.32%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -8.57% | -17.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -10.61% | -15.55% | |||
| Operating Income | 9.33% | 16.74% | |||
| Income Before Tax | 8.80% | 18.06% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 8.80% | 1.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.80% | 1.38% | |||
| EBIT | 9.33% | 16.74% | |||
| EBITDA | 9.41% | 16.88% | |||
| EPS Basic | 10.18% | 1.42% | |||
| Normalized Basic EPS | 10.20% | 18.08% | |||
| EPS Diluted | 10.18% | 1.42% | |||
| Normalized Diluted EPS | 10.20% | 18.08% | |||
| Average Basic Shares Outstanding | 1.55% | 0.03% | |||
| Average Diluted Shares Outstanding | 1.55% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||